期刊文献+

A型肉毒毒素用于注射美容的并发症及其防治措施 被引量:10

Complications of botulinum toxin type A in cosmetic use: preventions and management
下载PDF
导出
摘要 A型肉毒毒素是厌氧菌肉毒杆菌分泌的一种强效的神经毒素,它能够使肌肉麻痹、萎缩[1],其原理是,通过作用于横纹肌运动终板,抑制神经突触前膜乙酰胆碱的释放,阻止神经递质的传递,从而使肌肉收缩受到抑制,出现废用性萎缩[2]。自2002年4月被FDA批准用于眉间皱纹的美容治疗以来,A型肉毒毒素的注射已经成为一种十分常见的医学美容手段,广泛用于额前、眼周、口周和颈部区域的除皱,以及面部形态不对称和面肌抽搐的治疗[3-4]。
作者 梁筱 李青峰
出处 《中国美容医学》 CAS 2014年第16期1393-1397,共5页 Chinese Journal of Aesthetic Medicine
  • 相关文献

参考文献22

  • 1Mandel L,Tharakan M.Treatment of unilateral masseteric hypertrophy with botulinum toxin:Case report[J].J Oral Maxillofac Surg,1999,57(8):1017-1019.
  • 2Fujikawa R,Muroi Y,Unno T,et al.Ouabain exacerbates botulinum neurotoxin-induced muscle paralysis via progression of muscle atrophy in mice[J].J Toxicol Sci,2010,35(6):795-805.
  • 3Cote TR,Mohan AK,Polder JA,et al.Botulinum toxin type A injections:adverse events reported to the US Food aud Drug Administration in therapeutic and cosmetic cases[J].J Am Acad Dermatol,2005,53(3):407-415.
  • 4Stephan S,Wang TD.Botulinum Toxin:Clinical Techniques,Applications,and Complications[J].Facial Plast Surg,2011,27(6):529-539.
  • 5金云波,林晓曦.应用A型肉毒毒素的并发症和安全性研究进展[J].中华医学美学美容杂志,2010,16(6):425-427. 被引量:20
  • 6Khan TT,Herne K,Dayan SH,et al.Facial blanching due to neurotoxins:proposed mechanisms[J].Dermatol Surg,2013,39(1 Pt 1):24-29.
  • 7Gartlan MG,Hoffman HT.Crystalline preparation of botulinum toxin type A (Botox):degradation in potency with storage[J].Otolaryngol Head Neck Surg,1993,108 (2):135-140.
  • 8Assmann T,Krahl D,Mang R.Cutaneous sarcoidal granuloma after botulinum toxin type A injection[J].J Am Acad Dermatol,2013,69(5):e247-e249.
  • 9Pontes HA,Pontes FS,de Oliveira GF,et al.Uncommon foreign body reaction caused by botulinum toxin[J].J Craniofac Surg,2012,23(4):e303-305.
  • 10Skaf GS,Domloj NT,Salameh JA,et al.Pseudoaneurysm of the superficial temporal artery:a complication of botulinum toxin injection[J].Aesthetic Plast Surg,2012,36(4):982-985.

二级参考文献29

  • 1Erbguth F.Botulinum toxin:a historical note.Lancet,1998,351(9118):1820.
  • 2Scott AB,Rosenbaum A,Collins CC.Pharmacologic weakening of extraocular muscles.Invest Ophthalmol Vis Sci,1973,12(12):924-927.
  • 3Carruthers JD,Carruthers JA.Complications of botulinum toxin type A.Facial Plast Surg Clin North Am,2007,15(1):51-54.
  • 4Klein AW.Complications,adverse reactions,and insights with the use of botulinum toxin.Dermatol Surg,2003,29(5):549-556.
  • 5Carruthers J.Carruthers A,Dessain A.A singlecentre,double-blind,randomized,placebocontrolled study of the safety and efficacy of botulinum toxin type A treatment of upper facial rhytides in female subjects.J Am Acad Dermatol,2006,54(3):228-235.
  • 6Hsiung GY,Das SK,Ranawaya R,et al.Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.Mov Disord,2002,17(6):1288-1293.
  • 7[l8]Naumann M,Jankovic J.Safety of botulinum toxin type A:a systematic review and meta-analysis.Curr Med Res Opin,2004,20(7):981-990.
  • 8Mejia NI,Vuong KD,Jankovic J.Long-term botulinum toxin efficacy,safety,and immunogenicity.Mov Disord,2005,20(5):592-597.
  • 9Defazio G,Abbruzzese G,Girlanda P,et al.Botulinum toxin A treatment for primary hemifacial spasm:a 10-year multicenter study.Arch Neuro,2002,59(3):418-420.
  • 10Sankhla C,Sankovic J,Duane D.Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.Mov Discord,1998,13(1):150-154.

共引文献19

同被引文献86

引证文献10

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部